• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMerck

Merck

Page 6 of 10
Petya ransomware cyber attack
Tech
Ransomware Cost Surpasses $25 Million Mark
By Barb DarrowJuly 27, 2017
Johnson & Johnson’s Pricey Best-Selling Drug Will Have to Face a 35% Cheaper Rival
Health
Johnson & Johnson’s Pricey Best-Selling Drug Will Have to Face a 35% Cheaper Rival
By Sy MukherjeeJuly 24, 2017
Tuesday’s Massive Cyber Attacks Hit U.S. Drug Giant Merck
Health
Tuesday’s Massive Cyber Attacks Hit U.S. Drug Giant Merck
By Sy MukherjeeJune 27, 2017
These Are the Known Targets in the Petya Ransomware Attack So Far
Tech
These Are the Known Targets in the Petya Ransomware Attack So Far
By ReutersJune 27, 2017
Forbes Under 30 Summit
Health
This 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck
By Sy MukherjeeJune 6, 2017
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance
Why Drug Giant AstraZeneca’s Stock Soared More Than 9% on Friday
By Sy MukherjeeMay 12, 2017
Why Merck’s Keytruda Just Became a Lung Cancer Game Changer
Health
Why Merck’s Keytruda Just Became a Lung Cancer Game Changer
By Sy MukherjeeMay 11, 2017
FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller
Health
FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller
By Sy MukherjeeApril 24, 2017
Another Failure in Alzheimer’s. Another Shrug.
Health
Another Failure in Alzheimer’s. Another Shrug.
By Clifton LeafFebruary 15, 2017
Pharmaceutical Production Inside Merck KGaA Health Care Laboratory
Health
This Pharma Giant Just Pulled Back the Curtain On Its Drug Price Hikes
By Sy MukherjeeJanuary 29, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Decline With Banks, Health Shares Lower
Health
Why These Two Pharma Stocks Are Having Drastically Different Days
By Sy MukherjeeJanuary 20, 2017
The logo of German pharmaceuticals company Merck is seen in front of the company's headquarters in Darmstadt
Tech
Palantir’s Bet on Big Pharma
By Michal Lev-RamJanuary 12, 2017
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
Health
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By Sy MukherjeeJanuary 7, 2017
Hepatitis C drug can cure, if patients can get it
Health
Merck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By ReutersDecember 15, 2016
Cancer Consulting Elderly Person
Health
Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By Sy MukherjeeOctober 10, 2016
1...
  • 4
  • 5
  • 6
  • 7
  • 8
...10
Most Popular
Economy
Florida voters nearly tripled the homeowner tax break — blowing an $11.8 billion hole in county budgetsplaceholder alt text
By Abigail Hall, Aaron D. Wood and The ConversationNovember 6, 2026
Politics
'Like being hit between the eyes with a sledgehammer': Meet the one town in America that defied election trends and voted in favor of data centersplaceholder alt text
By Sasha RogelbergNovember 7, 2026
Personal Finance
Mark Zuckerberg’s fortune tops $200 billion. His 3 daughters won’t inherit most of itplaceholder alt text
By Emma WitmanNovember 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.